Log in to search using one of your social media accounts:

 

Progress in Fatty Liver and Pediatric Liver Disease Progress in Fatty Liver and Pediatric Liver Disease
New findings on nonalcoholic steatohepatitis, pediatric liver diseases, hepatitis B, and the microbiome will be among the topics tackled at the upcoming Liver Meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Too Much Sugar Can Harm Livers of Even Healthy Men
Study found an unhealthy buildup of fat in the vital organ when men switched to high-sugar diet Source: HealthDay Related MedlinePlus Pages: Carbohydrates, Fatty Liver Disease, Men's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 6, 2017 Category: Consumer Health News Source Type: news

Medical News Today: High-sugar diets raise heart disease risk in healthy people
A study finds that a high-sugar diet changes a healthy person's fat metabolism so that it resembles that of someone with non-alcoholic fatty liver disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 6, 2017 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Stop Your Body Attacking Itself
Modern medicine has no cure for autoimmune diseases — and, sadly, most doctors don’t understand them. I’m talking about disorders like rheumatoid arthritis, type 1 diabetes, lupus, fibromyalgia, chronic fatigue syndrome, psoriasis, multiple sclerosis (MS) and more. In all, there are about 80 autoimmune diseases affecting organs throughout the body. They occur when your own immune system becomes overactive and attacks your body instead of diseases and foreign invaders. The standard mainstream treatment for most autoimmune disorders relies on Big Pharma drugs that cover up symptoms or suppress your immun...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

Worse than liquor for your liver
Most people think liver disease only happens to alcoholics. But the truth is that being overweight or obese actually puts you at a much higher risk for liver damage than alcohol. In fact, alcohol contributes to only 6% of liver damage. But obesity contributes to 52% of liver disease. And if you’re obese, you’re 400% more likely to develop liver damage than a normal-weight individual.1 That’s why about 30% of people in America have some form of chronic fatty liver disease. It’s called non-alcoholic fatty liver disease (NAFLD). NAFLD causes painful swelling and scarring of the liver.  And I blame...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Health Weight Loss Source Type: news

Diabetes diet: Eating THIS could irreversibly HARM liver as well as cause type 2 diabetes
DIABETES is known to be driven by fructose sugar that ’s often added to processed foods. Now new research has found fructose could also cause fatty liver disease. (Source: Daily Express - Health)
Source: Daily Express - Health - October 5, 2017 Category: Consumer Health News Source Type: news

GM soybean oil leads to less obesity and insulin resistance but is still harmful to liver
According to a study, published inNature Scientific Reports, although a genetically-modified soybean oil was associated with lower risk of obesity and insulin resistance, it did not have beneficial effects on risk of diabetes or fatty liver disease.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 4, 2017 Category: Endocrinology Source Type: news

GM soybean oil causes less obesity and insulin resistance but is harmful to liver function
(University of California - Riverside) Researchers at the University of California, Riverside have tested a genetically-modified soybean oil used in restaurants and found that while it induces less obesity and insulin resistance than conventional soybean oil, its effects on diabetes and fatty liver are similar to those of conventional soybean oil, the major vegetable cooking oil used in the United States, with popularity on the increase worldwide. The study also compares the GM soybean oil to coconut and olive oils. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 2, 2017 Category: International Medicine & Public Health Source Type: news

Rosetrees Trust Interdisciplinary Prize awarded to Hebrew University scientists
(The Hebrew University of Jerusalem) The Rosetrees Trust Interdisciplinary Prize for 2017 has been awarded to two scientists from the Hebrew University of Jerusalem, Prof. Yaakov Nahmias and Prof. Nir Friedman, for their research proposal to engineer a platform that mimics the physiological dynamics of human metabolism. The research will be instrumental to drug development, offering a route to the rational design of therapeutics for obesity, fatty liver disease and type 2 diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2017 Category: International Medicine & Public Health Source Type: news

Medical News Today: Do you have diabetes, liver disease? Watch out for CVD
A new study shows that non-alcoholic fatty liver disease puts people with type 2 diabetes at a much higher risk of cardiovascular disease and death. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 13, 2017 Category: Consumer Health News Tags: Diabetes Source Type: news

Trigger for fatty liver in obesity
(University of Zurich) Morbid obesity affects the liver: almost one-third of all adults suffer from chronic fatty liver disease, which can lead to infections and even trigger cancer. Researchers at the University Children's Hospital Zurich and the University of Zurich have now found a signaling pathway in cells that play an important role in the development of fatty liver disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 7, 2017 Category: Cancer & Oncology Source Type: news

Heart Benefit of Alcohol Not Seen in NAFLD Heart Benefit of Alcohol Not Seen in NAFLD
Light to moderate drinkers may have a lower risk of heart disease than teetotalers, but a new study suggests this doesn't hold true in non-alcoholic fatty liver disease (NAFLD).Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 7, 2017 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Heart benefit of alcohol not seen in people with liver disease
(Reuters Health) - Light to moderate drinkers may have a lower risk of heart disease than teetotalers, but a new study suggests this doesn ’t hold true for people with fatty liver disease. (Source: Reuters: Health)
Source: Reuters: Health - September 4, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Nonalcoholic Fatty Liver Disease Epidemic Increasing Greatly Nonalcoholic Fatty Liver Disease Epidemic Increasing Greatly
The burden of nonalcoholic fatty liver disease (NAFLD) is increasing greatly, and the need for liver transplants is likely to outstrip the supply of donors, researchers report.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - August 31, 2017 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Enzyme produced in the liver promotes obesity, fatty liver disease and insulin resistance
In mice given a high fat diet, an increased production of the enzyme DPP4 by the liver promotes an increase in body fat, the development of fatty liver disease and insulin resistance. According to the study, published in Molecular Metabolism, DPP4 production is therefore a cause rather than result of fatty liver and insulin resistance.Science Daily  (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 25, 2017 Category: Endocrinology Source Type: news

Heart hormones protect against obesity and insulin resistance
(Sanford-Burnham Prebys Medical Discovery Institute) By fleshing out how one signaling receptor contributes to causing obesity through its activity in fatty tissue but not in muscle cells, SBP scientists have zeroed in on an important new avenue of exploration for combating metabolic disease. More than one-third of American adults are considered to be obese, which dramatically increases their risk for developing type 2 diabetes, non-alcoholic fatty liver disease, high blood pressure, and multiple inflammatory conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2017 Category: International Medicine & Public Health Source Type: news

Enzyme produced in the liver promotes obesity, fatty liver disease and insulin resistance
(Deutsches Zentrum fuer Diabetesforschung DZD) In mice that are given a high-fat diet, an increased production of the enzyme DPP4* by the liver promotes an increase in body fat, the development of fatty liver disease and insulin resistance. These were the findings of a current study by DZD-researchers in Potsdam and T ü bingen. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2017 Category: International Medicine & Public Health Source Type: news

Fatty liver can cause damage to other organs
NAFLD increases the risk of chronic liver disease, type 2 diabetes and cardiovascular diseases by releasing glucose, fats and proteins into the bloodstream, according to research published inScientific Reports. The secreted substances trigger reactions in other organs, causing further damage. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 22, 2017 Category: Endocrinology Source Type: news

Your NEJM Group Today: Migraine Clinical Pearls / Alcohol Intake in Nonalcoholic Fatty Liver Disease / Okla. Primary Care Opportunity (FREE)
By the Editors Take a look at today's offering from NEJM Group:NEJM Resident 360: Clinical Pearls: Are … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 22, 2017 Category: Primary Care Source Type: news

Fatty liver disease: Complex condition can also damage other organs
NON-ALCOHOLIC fatty liver disease is a condition usually seen in people who are obese or overweight. (Source: Daily Express - Health)
Source: Daily Express - Health - August 21, 2017 Category: Consumer Health News Source Type: news

Organ crosstalk: Fatty liver can cause damage to other organs
(Deutsches Zentrum fuer Diabetesforschung DZD) Scientists of the German Center for Diabetes Research (DZD) in T ü bingen discovered that a fatty liver can cause damage to other organs. In two just-published studies they demonstrate the effects of fatty liver disease on the function of the hormone-producing islet cells in the pancreas and on renal function. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 18, 2017 Category: International Medicine & Public Health Source Type: news

Alcohol warning: THIS trendy spice can protect you from liver disease caused by drinking
ALCOHOL consumed in large amounts is the main cause in the Western world of liver disease, which includes fatty liver, alcoholic hepatitis, and chronic hepatitis with liver fibrosis or cirrhosis. However, a popular spice may provide a beneficial effect if you ’ve overdone the drinking. (Source: Daily Express - Health)
Source: Daily Express - Health - August 15, 2017 Category: Consumer Health News Source Type: news

Cutting high fructose corn syrup from diet can reverse insulin resistance and high cholesterol
A study, published inThe Journal of the American Osteopathic Association suggests that removing fructose from the diet can combat obesity, fatty liver disease, diabetes and insulin resistance.Express (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 15, 2017 Category: Endocrinology Source Type: news

Ditching THIS sugar in fizzy drinks 'can combat obesity, fatty liver disease and diabetes'
DITCHING a type of sugar found in fizzy drinks and cakes can combat obesity, fatty liver disease and diabetes - and the results can be seen in just eight days. (Source: Daily Express - Health)
Source: Daily Express - Health - August 11, 2017 Category: Consumer Health News Source Type: news

Antiviral and anti-fatty liver
(Source: ScienceNOW)
Source: ScienceNOW - August 10, 2017 Category: Science Authors: Wong, W. Tags: twis Source Type: news

TRIF-dependent Toll-like receptor signaling suppresses Scd1 transcription in hepatocytes and prevents diet-induced hepatic steatosis
Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of diseases that ranges in severity from hepatic steatosis to steatohepatitis, the latter of which is a major predisposing factor for liver cirrhosis and cancer. Toll-like receptor (TLR) signaling, which is critical for innate immunity, is generally believed to aggravate disease progression by inducing inflammation. Unexpectedly, we found that deficiency in TIR domain–containing adaptor-inducing interferon-β (TRIF), a cytosolic adaptor that transduces some TLR signals, worsened hepatic steatosis induced by a high-fat diet (HFD) and that such exacerbati...
Source: Signal Transduction Knowledge Environment - August 8, 2017 Category: Science Authors: Chen, J., Li, J., Yiu, J. H. C., Lam, J. K. W., Wong, C.-M., Dorweiler, B., Xu, A., Woo, C. W. Tags: STKE Research Articles Source Type: news

Reverse fatty liver disease: Drug could CURE condition caused by obesity
NON-alcoholic fatty liver disease is a condition usually seen in people who are obese or overweight, however now experts think there could be a cure. (Source: Daily Express - Health)
Source: Daily Express - Health - August 4, 2017 Category: Consumer Health News Source Type: news

Of Mice and Cheeseburgers: Experimental Drug Reverses Obesity-Related Liver Disease
A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet – non-alcoholic fatty liver disease. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - August 3, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Of mice and cheeseburgers: Experimental drug reverses obesity-related liver disease
(University of Rochester Medical Center) An experimental drug protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet -- non-alcoholic fatty liver disease. The drug reversed liver inflammation, injury and scarring in animals fed a high fat, sugar and cholesterol diet. The diet was designed to replicate the Western fast food diet and recreate the features of non-alcoholic fatty liver disease found in people. The research team plans further testing to move it into human trials. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 3, 2017 Category: International Medicine & Public Health Source Type: news

Can-Fite commences Phase II trial of namodenoson for NAFLD/NASH
Israeli biotechnology firm Can-Fite BioPharma is set to commence patient enrolment for a Phase II clinical trial of namodenoson to treat non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), following the successful conc … (Source: Drug Development Technology)
Source: Drug Development Technology - July 18, 2017 Category: Pharmaceuticals Source Type: news

Obscure Asthma Drug Shows Promise for Treating Diabetes Obscure Asthma Drug Shows Promise for Treating Diabetes
A small proof-of-concept study has suggested that the asthma drug amlexanox could be repurposed to treat type 2 diabetes and may improve nonalcoholic fatty-liver disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Papers of note in Science Translational Medicine 9 (396)
This week’s articles describe ways to potentially treat lymphoma and fatty liver–associated fibrosis. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - July 4, 2017 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

Improving VNS therapy: ElectroCore CEO Amato on gammaCore and its slated July launch
Neuroscience tech developer ElectroCore said recently it plans to launch its handheld gammaCore vagus nerve stimulation device in the US in mid-July, after having won clearance from the FDA in April for treating episodic cluster headaches. Unlike other vagus nerve stimulation devices, the gammaCore is an external handheld device with no implanted component, designed to be used in a pain-free procedure, CEO Frank Amato told MassDevice.com in an interview. “Its a first-of-its-kind type of device,” Amato said, speaking on the recently approved and soon-to-launch gammaCore. “Vagus nerve stimulators have been ...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management Source Type: news

Is Lipitor Safe if I Have Fatty Liver?
Title: Is Lipitor Safe if I Have Fatty Liver?Category: Doctor's& Expert's views on SymptomsCreated: 6/29/2017 12:00:00 AMLast Editorial Review: 6/29/2017 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - June 29, 2017 Category: Cardiology Source Type: news

Reversing a common liver disease
Eliminating old or damaged cells that have stopped dividing reduced signs of fatty liver disease in mice. The findings are an important clue for developing treatments. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - June 27, 2017 Category: Consumer Health News Source Type: news

Relatives of people with fatty liver cirrhosis also at risk
(Reuters Health) - If a parent or sibling has cirrhosis due to non-alcoholic fatty liver disease, a person's odds of having liver scarring are more than 12 times higher than for people without close relatives who have this condition, a small study finds. (Source: Reuters: Health)
Source: Reuters: Health - June 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Popular prostate drug linked to serious side effects
(Boston University Medical Center) Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2017 Category: International Medicine & Public Health Source Type: news

New study: Unsaturated fat associated with fatty liver disease
(American Gastroenterological Association) As the obesity epidemic continues, new data shed light on which nutrients and what quantity of those nutrients promote health or disease. In the American Gastroenterological Association journal, Cellular and Molecular Gastroenterology and Hepatology, scientists report on the role of macronutrients in the development of metabolically unhealthy obesity -- cases where patients have diseases with obesity as the root cause, specifically nonalcoholic fatty liver disease (NAFLD). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 14, 2017 Category: Biology Source Type: news

Can Coffee, Tea Protect the Liver From Bad Diet?
These beverages may help guard against fatty liver disease, early research suggests (Source: WebMD Health)
Source: WebMD Health - June 13, 2017 Category: Consumer Health News Source Type: news

Fatty liver disease cure? Hope to millions as killer illness reversed for first time
A KILLER liver disease caused by overeating has been reversed for the first time, offering hope to millions of Britons. (Source: Daily Express - Health)
Source: Daily Express - Health - June 13, 2017 Category: Consumer Health News Source Type: news

Scientists reverse mechanism of fatty liver disease
(Newcastle University) Researchers have identified the mechanism which causes a build-up of fat in the liver in a disease affecting one in five in the UK -- and were able to reverse it in a mouse model. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 13, 2017 Category: Cancer & Oncology Source Type: news

Short duration of breastfeeding and maternal obesity linked to fatty liver in adolescents
(Elsevier) Infants who were breastfed for less than six months before starting infant formula milk and infants who had mothers who were obese at the start of pregnancy, were much more likely to develop nonalcoholic fatty liver disease (NAFLD) as adolescents, according to a novel study in the Journal of Hepatology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2017 Category: International Medicine & Public Health Source Type: news

Type of sugar may treat atherosclerosis, mouse study shows
Researchers have long sought ways to harness the body's immune system to treat disease, especially cancer. Now, scientists have found that the immune system may be triggered to treat atherosclerosis and possibly other metabolic conditions, including fatty liver disease and type 2 diabetes. Studying mice, researchers at Washington University School of Medicine in St. Louis have shown that a natural sugar called trehalose revs up the immune system's cellular housekeeping abilities. (Source: World Pharma News)
Source: World Pharma News - June 8, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Cellular stress in the brain may contribute to non-alcoholic fatty liver disease
(George Washington University) Research published in the Journal of Clinical Investigation Insight shows that cellular stress in the brain may contribute to development of nonalcoholic fatty liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2017 Category: International Medicine & Public Health Source Type: news

World's leading liver experts focus on continuing advancements in liver disease & transplantation
(Intermountain Medical Center) As the prevalence of liver disease continues to rise across the world, the growing number of people impacted by cirrhosis, liver cancer, and nonalcoholic fatty liver disease, is the focus of more than 1,700 of the world's leading liver disease experts. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 24, 2017 Category: Infectious Diseases Source Type: news

Fractyl Labs launches Revita DMR diabetic treatment study
Fractyl Laboratories said today it launched the Revita-2 clinical trial of its Revita DMR procedure in orally-treated type 2 diabetes patients with poorly controlled disease. The company said that it has enrolled the 1st patient in the trial at a European center participating in the study. The Revita DMR is a minimally invasive procedure designed to ablate and ‘rejuvenate’ the duodenum (the 1st part of the intestine) in order to alter glucose metabolism, the Lexington, Mass.-based company said. “Untreated insulin resistance can lead to more severe diseases including fatty liver disease and NASH....
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Diabetes Fractyl Laboratories Source Type: news

Media Advisory: Intestinal fungi linked to worsening of alcoholic liver disease
 What A new study funded by the National Institute on Alcohol Abuse and Alcoholism is among the first to suggest that intestinal fungi may contribute to the development of alcoholic liver disease (ALD). ALD encompasses a broad range of liver diseases, from simple steatosis (fatty liver) to end-stage liver disease, or cirrhosis (liver cell death). Liver cirrhosis is the 12th leading cause of mortality worldwide, with approximately half of those deaths due to alcohol misuse.   (Source: NIAAA News)
Source: NIAAA News - May 22, 2017 Category: Addiction Authors: groa Source Type: news

Nonobese Fatty Liver Disease Nonobese Fatty Liver Disease
What is the clinical significance of nonobese NAFLD as a liver disease, and how can we identify at-risk patients?Clinical Gastroenterology and Hepatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 19, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Alcohol abstention advice to pregnant women is wrong, say campaigners
Campaigners claim alcohol abstention advice to pregnant women is overly cautious Related items fromOnMedica Online abortion service can offer alternative to unsafe methods Epilepsy drug linked to 4,000 birth defects in France Birth weight linked to fatty liver disease Hunt orders inquiry into baby deaths High Court says doctors can withdraw ventilation from baby Charlie (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 18, 2017 Category: UK Health Source Type: news

Genes and BMI conspire to make fatty liver
(Source: ScienceNOW)
Source: ScienceNOW - May 18, 2017 Category: Science Authors: Kiberstis, P. A. Tags: twil Source Type: news